Germany must make the COVID-19 vaccine from Johnson & Johnson (JNJ.N) available to all adults, Health Minister Jens Spahn said on Monday, adding that they will be able to receive the vaccine on the advice of ‘doctor.
The European drugs regulator backed J & J’s vaccine last month after reviewing cases of a rare blood clotting problem in American adults who were given a dose. But it left it up to the member states of the European Union to decide how to use it. Read more
Germany’s decision to offer the single-dose J&J vaccine largely follows the lifting of restrictions last week on the AstraZeneca vaccine (AZN.L).
The AstraZeneca vaccine had been restricted to people over the age of 60 following similar reports of very rare but sometimes fatal clotting events in younger people, with women disproportionately affected. Read more
The decisions reflect Germany’s progress in vaccinating its elders, Spahn said, adding that he expected all people aged 60 and over who wanted to be vaccinated to be offered a vaccine. ‘by the end of May or early June.
With millions of doses of J&J expected to arrive later in the second quarter of this year, it made sense to make the vaccine more widely available, he added.
Spahn predicted that 10 million doses of the J&J vaccine should arrive in Germany by the end of the second quarter.
Our Standards: Thomson Reuters Trust Principles.